The National Institute of Sanitary Management (INGESA) has modified the contract documents for the centralized purchase of biological medicines with biosimilars for autonomous communities and agencies of the General State Administration. In the new specifications, the price of four lots and the access conditions are slightly varied to favor a greater number of bidders.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
